- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04742660
The Effect of Glycyrrhizin on the Occurrence of Postoperative Nausea and Vomiting
The Effect of Administration of Glycyrrhizin During Induction Period on the Occurrence of Postoperative Nausea and Vomiting After Breast Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Postoperative nausea and vomiting (PONV) is one of a common complication after general anesthesia with 30-50% of incidence, increased up to 80% in high risk group. The risk factors of PONV include women population, the previous history of PONV, motion sickness in usual life, non-smoker, exposure to inhalants, perioperative opioid and laparoscopic surgery. Women population is a strong risk factor of PONV. Although perioperative management of PONV based on a guideline has been done in a lot of medical centers worldwide, the incidence of PONV is still reported relatively high.
The main ingredient of Glycyrrhizin is liquorice which has been used as antispasmodics, antiemetics or treatment for gastric ulcer in oriental medicine. Utilizing these effects of liquorice, the investigators investigate whether the addition of glycyrrhzin to conventional antiemetics is effective to decrease the incidence of PONV and improvement of severity of PONV.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Seoul-T'ǔkpyǒlshi
-
Seoul, Seoul-T'ǔkpyǒlshi, Korea, Republic of, 05030
- Konkuk University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- participants scheduled to undergo breast surgery aged 20 and above
Exclusion Criteria:
- aldosteronism
- electrolyte imbalance
- myopathies
- drug addiction or suspected
- bowel disease
- allergy to drugs
- smoker
- taking any medications
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: group R
Participants are administered a dose of 0.3mg of ramosetron (conventional antiemetics) intravenously followed by continuous infusion of 120mL normal saline at a rate of 10mL/min.
|
In control group, we assess the incidence and severity of PONV when participants are aministered ramosetron and placebo.
In intervention group, the outcomes are assessed as a result of administration of ramosetron and glycyrrhizin.
Other Names:
|
ACTIVE_COMPARATOR: group G
participants are administered a dose of 0.3mg of ramosetron followed by continuous infusion of mixture of 20mL glycyrrhizin and 100mL normal saline (total 120mL) at a rate of 10mL/min.
|
In control group, we assess the incidence and severity of PONV when participants are aministered ramosetron and placebo.
In intervention group, the outcomes are assessed as a result of administration of ramosetron and glycyrrhizin.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the incidence of postoperative nausea and vomiting (PONV)
Time Frame: up to 24 hours after discharge from postanesthetic care unit (PACU)
|
assessing the incidence of postoperative nausea and vomiting with ordinal scale (0=none, 1=nausea, 2=retching, 3= vomiting)
|
up to 24 hours after discharge from postanesthetic care unit (PACU)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Sung-Hyop Kim, M.D. Ph.D, Konkuk University Medical Center
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KUH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Nausea
-
Cukurova UniversityTarsus UniversityRecruitingNausea, Postoperative | Vomiting, Postoperative | APFEL RİSK SCORETurkey
-
Ospedale Misericordia e DolceUnknownPostoperative Pain | Thyroidectomy | Postoperative Nausea and Vomit | Postoperative Vocal FunctionItaly
-
Lancaster General HospitalCompletedBariatric Surgery Candidate | Nausea, PostoperativeUnited States
-
Northwell HealthTerminatedPostoperative Pain | Postoperative Nausea | Postoperative VomitingUnited States
-
Hôpital Privé de Parly II - Le ChesnayCompletedPostoperative Nausea | Postoperative Vomiting | Postoperative EmesisFrance
-
Yeungnam University College of MedicineCompletedPostoperative Nausea | Postoperative VomitingKorea, Republic of
-
Methodist Health SystemRecruitingNausea, Postoperative | Vomiting, PostoperativeUnited States
-
Sevgi GürCompletedPostoperative Nausea and VomitingTurkey
-
Khon Kaen UniversityCompleted
Clinical Trials on Ammonium Glycyrrhizinate
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
CttqUnknownChronic Hepatitis b | Liver Inflammation
-
Eli Lilly and CompanyCompletedHealthy SubjectsUnited Kingdom
-
Queen's UniversityCompleted
-
Duke UniversityCompletedHealthcare Associated Infections | Multidrug Resistant OrganismsUnited States
-
I.M. Sechenov First Moscow State Medical UniversityCompletedMenopause Related ConditionsRussian Federation
-
Icahn School of Medicine at Mount SinaiCompleted
-
Indonesia UniversityCompletedXerosis CutisIndonesia
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingHeart Failure | Diuretic ResistanceUnited States